A detailed history of Invesco Ltd. transactions in Puma Biotechnology, Inc. stock. As of the latest transaction made, Invesco Ltd. holds 18,742 shares of PBYI stock, worth $60,536. This represents 0.0% of its overall portfolio holdings.

Number of Shares
18,742
Previous 118,832 84.23%
Holding current value
$60,536
Previous $387,000 87.86%
% of portfolio
0.0%
Previous 0.0%

Shares

8 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 12, 2024

SELL
$2.25 - $4.03 $225,202 - $403,362
-100,090 Reduced 84.23%
18,742 $47,000
Q2 2024

Aug 13, 2024

BUY
$2.92 - $5.83 $346,989 - $692,790
118,832 New
118,832 $387,000
Q2 2022

Aug 15, 2022

SELL
$1.64 - $3.3 $19,442 - $39,121
-11,855 Closed
0 $0
Q1 2022

May 16, 2022

BUY
$2.13 - $3.24 $74 - $113
35 Added 0.3%
11,855 $34,000
Q4 2021

Feb 14, 2022

SELL
$2.85 - $6.58 $10,117 - $23,359
-3,550 Reduced 23.1%
11,820 $36,000
Q3 2021

Nov 15, 2021

BUY
$6.63 - $9.39 $16,873 - $23,897
2,545 Added 19.84%
15,370 $108,000
Q2 2021

Aug 17, 2021

BUY
$8.98 - $11.6 $17,780 - $22,968
1,980 Added 18.26%
12,825 $118,000
Q1 2021

May 17, 2021

BUY
$9.38 - $13.63 $101,726 - $147,817
10,845 New
10,845 $106,000

Others Institutions Holding PBYI

About PUMA BIOTECHNOLOGY, INC.


  • Ticker PBYI
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 45,556,000
  • Market Cap $147M
  • Description
  • Puma Biotechnology, Inc., a biopharmaceutical company, focuses on the development and commercialization of products to enhance cancer care in the United States and internationally. The company's drug candidates include PB272 neratinib (oral) for the patients with early stage HER2-overexpressed/amplified breast cancer; PB272 (neratinib, oral) for...
More about PBYI
Track This Portfolio

Track Invesco Ltd. Portfolio

Follow Invesco Ltd. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Invesco Ltd., based on Form 13F filings with the SEC.

News

Stay updated on Invesco Ltd. with notifications on news.